Last quarter (Q3 2025), Akebia Therapeutics's total revenue was $58.77M, an increase of 57.01% from the same quarter last year. In Q3, Akebia Therapeutics's net income was $540.00K. See Akebia Therapeutics’s key income statements, including revenue, expenses, profit, and income.

Income Statement	Dec 24	Dec 23	Dec 22	Dec 21	Dec 20
Total Revenue	$ 160.18M	$ 194.62M	$ 292.48M	$ 211.65M	$ 294.64M
Gross Profit	$ 97.00M	$ 120.47M	$ 269.99M	$ 130.16M	$ 230.68M
Operating Expenses	$ 147.47M	$ 166.73M	$ 350.77M	$ 394.66M	$ 608.51M
Depreciation and Amortization	$ 37.50M	$ 37.63M	$ 37.70M	$ 37.97M	$ 34.69M
EBITDA	$ -13.72M	$ -8.27M	$ 3.06M	$ -189.91M	$ -139.83M
Operating Income	$ -50.47M	$ -46.26M	$ -80.78M	$ -264.50M	$ -377.83M
Other Income/Expenses	$ -18.94M	$ -5.67M	$ -13.45M	$ -17.52M	$ -7.01M
Pretax Income	$ -69.41M	$ -51.92M	$ -94.23M	$ -282.02M	$ -384.84M
Net Income	$ -69.41M	$ -51.92M	$ -94.23M	$ -282.02M	$ -384.84M
Per Share Metrics
Basic EPS	$ -0.33	$ -0.28	$ -0.58	$ -1.48	$ -2.53
Diluted EPS	$ -0.33	$ -0.28	$ -0.58	$ -1.48	$ -2.53
Weighted Average Shares Outstanding	210.95M	187.47M	182.78M	165.95M	138.46M
Weighted Average Shares Outstanding (Diluted)	210.95M	187.47M	182.78M	165.95M	138.46M

Currency in USD

Akebia Therapeutics Earnings and Revenue History

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing